Author:
Majidpoor Jamal,Mortezaee Keywan
Subject
Immunology,Immunology and Allergy
Reference113 articles.
1. Immune escape: a critical hallmark in solid tumors;Mortezaee;Life Sci.,2020
2. PD-L1 mediates dysfunction in activated PD-1+ NK cells in head and neck cancer patients;Concha-Benavente;Cancer Immunol. Res.,2018
3. Pembrolizumab versus ipilimumab in advanced melanoma (KEYNOTE-006): post-hoc 5-year results from an open-label, multicentre, randomised, controlled, phase 3 study;Robert;Lancet Oncol.,2019
4. Pembrolizumab in Patients with Non-small-Cell Lung Cancer of Performance Status 2 (PePS2): A Single Arm, Phase 2 Trial;Middleton,2020
5. Pembrolizumab as neoadjuvant therapy before radical cystectomy in patients with muscle-invasive urothelial bladder carcinoma (PURE-01): an open-label, single-arm, phase II study;Necchi;J. Clin. Oncol.,2018
Cited by
119 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献